Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
New Covid Antiviral Pills Offer Hope as Omicron Loomsnews2021-12-07T08:00:09+00:00December 7th, 2021|The New York Times|
South African Company Nears License to Sell J. & J. Covid Shot Across Africanews2021-11-30T21:07:51+00:00November 30th, 2021|The New York Times|
¿Las vacunas funcionan para la variante ómicron?news2021-11-29T23:50:30+00:00November 29th, 2021|The New York Times|
Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.news2021-11-28T23:55:10+00:00November 28th, 2021|The New York Times|
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drugnews2021-11-22T16:00:09+00:00November 22nd, 2021|The New York Times|
Opioid Makers Win Major Victory in California Trialnews2021-11-02T16:51:06+00:00November 2nd, 2021|The New York Times|
Why Aren’t More People Comparison Shopping for Health Plans?news2021-10-30T09:00:21+00:00October 30th, 2021|The New York Times|
How the Delta Variant is Pushing Americans to Get Vaccinatednews2021-09-28T19:24:33+00:00September 28th, 2021|The New York Times|
